Clinical Trials
Unequitable Heart Failure Therapy for Black, Hispanic and American-Indian Patients
Review
doi: 10.15420/cfr.2022.02.
eCollection 2022 Jan.
Affiliations
Expand
...
ASCO Spotlight With Hope S. Rugo, MD, FASCO, on Clinical Trial Minority Recruitment, PALOMA-2 Findings
Hope S. Rugo, MD, FASCO, is a professor of medicine and director of Breast Oncology and Clinical Trials Education at the University of California, ...
Initiative to increase minority representation in clinical trials
The goal after an 18-month pilot phase is to have a framework in place to change medical trials nationwide.
ATLANTA — As vaccines for COVID-19 we...
Implementing a self-monitoring application during pregnancy and postpartum for rural and underserved women: A qualitative needs assessment study
Abstract
Background
Georgia has one of the highest maternal mortality rates within the US. This study describes the qualitative needs assessment...
UT Southwestern Is Nation’s First Academic Medical Center for Chemical Society’s Minority Recruitment Program
Newswise — UT Southwestern Medical Center has been selected as the nation’s first academic medical center to participate in the American Chemical S...
Race, Ethnicity Underreported in Early Phase Pediatric Cancer Trials
Patient race and ethnicity are underreported in early phase pediatric cancer trials, according to research published in The Oncologist.
Race and et...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
